Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06102499

Comparison of Pulse Oximetry (SpO2) With Different Oximeters and Arterial Saturation (SaO2): Oxygap2 Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Laval University · Academic / Other
Sex
All
Age
0 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The oximeter is used to monitor intensive care patients undergoing oxygen therapy. It indicates pulsed oxygen saturation (SpO2), a reflection of arterial oxygen saturation (SaO2) which enables detection of hypoxemia and hyperoxia, both deleterious state. Current SpO2 recommendations aim to reduce both risk of hypoxemia and hyperoxia. SpO2 is considered the 5th vital sign. Current recommendations for SpO2 targets do not consider the variability of oximeters used in clinical practice. This variability and lack of specification represent an obstacle to an optimal practice of oxygen therapy. Thus, this study aims to compare the SpO2 values of different oximeters (General Electric-GE, Medtronic, Masimo and Nonin) used in clinical practice with the SaO2 reference value obtained by an arterial gas in order to specify the precision and the systematic biases of the oximeters studied. This data will also make it possible to refine the recommendations concerning optimal oxygenation

Conditions

Interventions

TypeNameDescription
DEVICESpO2 and SaO2 comparisonSeveral pulse oximeter will be place on patient find few minutes before arterial blood gases. During an arterial blood sample, all SpO2 will be recorded

Timeline

Start date
2024-06-20
Primary completion
2026-06-30
Completion
2026-12-30
First posted
2023-10-26
Last updated
2025-08-28

Locations

3 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT06102499. Inclusion in this directory is not an endorsement.